Phase 2 ILUSTRO trial (cohort 4): zolbetuximab + mFOLFOX6 + nivolumab in advanced gastric or gastroesophageal junction adenocarcinoma

Kohei Shitara et al.

Avacincaptad pegol for GA: 3-year results from the GATHER2 open-label extension trial
zolbemicrosite-unbranded-north-america-global-en-banner-mobile.png

Infographic

Presentation content summarized in plain language